Datasets

HealthData.Gov

Research Article: Journal of Biomedicine and Biotechnology

Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant mammary gland cells, was recently approved by the Food and Drug Administration (FDA) for the treatment of breast…